journal article·2020-11-11

Determining the Efficiency of Single Molecule Quantum Dot Labeling of HER2 in Breast Cancer Cells

Diana B. Peckys, Cedric Quint, Niels de Jonge

Nano Letters· Volume 20· Issue 11
Publisher page

Abstract

Quantum dots exhibit unique properties compared to other fluorophores, such as bright fluorescence and lack of photobleaching, resulting in their widespread utilization as fluorescent protein labels in the life sciences. However, their application is restricted to relative quantifications due to lacking knowledge about the labeling efficiency. We here present a strategy for determining the labeling efficiency of quantum dot labeling of HER2 in overexpressing breast cancer cells. Correlative light- and liquid-phase electron microscopy of whole cells was used to convert fluorescence intensities into the underlying molecular densities of the quantum dots. The labeling procedure with small affinity proteins was optimized yielding a maximal labeling efficiency of 83%, which was applicable to the high amount of ∼1.5 × 106 HER2 per cell. With the labeling efficiency known, it is now possible to derive the absolute protein expression levels in the plasma membrane and its variation within a cell and between cells.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Advanced Biosensing Techniques and Applications · Monoclonal and Polyclonal Antibodies Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Molecular Biophysics, Center for Integrative Physiology and Molecular Medicine, Saarland University, 66421 Homburg, Germany

Department of Physics, Saarland University, 66123 Saarbrücken, Germany

INM − Leibniz Institute for New Materials, 66123 Saarbrücken, Germany

Funding

Deutsche Forschungsgemeinschaft · Else Kr?ner-Fresenius-Stiftung

References (57)

Show source-provided references
1. 10.1016/j.biomaterials.2005.11.01810.1016/j.biomaterials.2005.11.018 ↗
2. 10.1038/nprot.2007.10710.1038/nprot.2007.107 ↗
3. 10.1038/nbt92710.1038/nbt927 ↗
4. 10.1021/nn101023210.1021/nn1010232 ↗
5. 10.1038/nmeth79110.1038/nmeth791 ↗
6. 10.1126/sciadv.150016510.1126/sciadv.1500165 ↗
7. 10.1007/s11051-014-2376-410.1007/s11051-014-2376-4 ↗
8. 10.3389/fimmu.2013.0042710.3389/fimmu.2013.00427 ↗
9. 10.1007/s00441-014-2087-210.1007/s00441-014-2087-2 ↗
10. 10.1038/ncomms1274210.1038/ncomms12742 ↗
11. 10.1016/j.bbamem.2014.12.01310.1016/j.bbamem.2014.12.013 ↗
12. 10.1021/nl303151f10.1021/nl303151f ↗
13. 10.1371/journal.pone.022533910.1371/journal.pone.0225339 ↗
14. 10.1111/jmi.1257010.1111/jmi.12570 ↗
15. 10.1091/mbc.E15-05-026910.1091/mbc.E15-05-0269 ↗
16. 10.1039/C9NR01105F10.1039/C9NR01105F ↗
17. 10.1007/7657_2018_1110.1007/7657_2018_11 ↗
18. 10.1038/s41598-019-49019-x10.1038/s41598-019-49019-x ↗
19. 10.1002/adma.20070198310.1002/adma.200701983 ↗
20. 10.1111/j.1365-2818.2008.01949.x10.1111/j.1365-2818.2008.01949.x ↗
21. 10.1016/j.yexcr.2015.07.01210.1016/j.yexcr.2015.07.012 ↗
22. 10.1155/2014/85274810.1155/2014/852748 ↗
23. 10.1016/0022-5193(66)90119-610.1016/0022-5193(66)90119-6 ↗
24. 10.3389/fbioe.2019.0018710.3389/fbioe.2019.00187 ↗
25. 10.1186/bcr286610.1186/bcr2866 ↗
26. 10.1371/journal.pone.002473910.1371/journal.pone.0024739 ↗
27. 10.1073/pnas.100502510710.1073/pnas.1005025107 ↗
28. 10.1016/j.molonc.2012.12.00310.1016/j.molonc.2012.12.003 ↗
29. 10.1016/j.tibtech.2017.04.00710.1016/j.tibtech.2017.04.007 ↗
30. 10.1158/0008-5472.CAN-05-352110.1158/0008-5472.CAN-05-3521 ↗
31. 10.1177/26.4.7786810.1177/26.4.77868 ↗
32. 10.1002/(SICI)1097-0320(19961101)25:3<271::AID-CYTO8>3.0.CO;2-I10.1002/(SICI)1097-0320(19961101)25:3<271::AID-CYTO8>3.0.CO;2-I ↗
33. 10.1016/j.bpj.2017.12.01110.1016/j.bpj.2017.12.011 ↗
34. 10.1091/mbc.e03-08-059610.1091/mbc.e03-08-0596 ↗
35. 10.1242/jcs.24035810.1242/jcs.240358 ↗
36. 10.1021/la503251s10.1021/la503251s ↗
37. 10.1177/26.8.35764510.1177/26.8.357645 ↗
38. 10.1242/jcs.14634010.1242/jcs.146340 ↗
39. 10.1021/acs.analchem.9b0023810.1021/acs.analchem.9b00238 ↗
40. 10.1002/cyto.a.2067710.1002/cyto.a.20677 ↗
41. 10.7554/eLife.1695010.7554/eLife.16950 ↗
42. 10.1093/nar/gkt136410.1093/nar/gkt1364 ↗
43. 10.1038/s41598-018-33225-010.1038/s41598-018-33225-0 ↗
44. 10.3389/fonc.2013.0012910.3389/fonc.2013.00129 ↗
45. 10.1002/elps.20120030410.1002/elps.201200304 ↗
46. 10.1021/acs.nanolett.9b0223210.1021/acs.nanolett.9b02232 ↗
47. 10.1038/nbt96210.1038/nbt962 ↗
48. 10.1038/nbt112710.1038/nbt1127 ↗
49. 10.1038/s41467-018-06271-510.1038/s41467-018-06271-5 ↗
50. 10.1038/srep2816310.1038/srep28163 ↗
51. 10.1016/j.cplett.2018.06.01910.1016/j.cplett.2018.06.019 ↗
52. 10.1093/cercor/bhr22510.1093/cercor/bhr225 ↗
53. 10.1242/jcs.06173910.1242/jcs.061739 ↗
54. 10.1111/j.1365-2559.2010.03494.x10.1111/j.1365-2559.2010.03494.x ↗
55. 10.1016/j.celrep.2015.12.00210.1016/j.celrep.2015.12.002 ↗
56. Tomlinson I. D. · 2005 · 5110.1385/1-59259-901-X:051 ↗
57. 10.1186/s10020-019-0108-z10.1186/s10020-019-0108-z ↗